
Aptorum Group Limited APM
$ 0.87
2.42%
Annual report 2026
added 05-14-2026
Aptorum Group Limited Operating Cycle 2011-2026 | APM
Annual Operating Cycle Aptorum Group Limited
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 106 | 28.7 | 4.89 | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 106 | 1.35 | 29.4 |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
3.11 K | - | 5743.5 % | $ 69.7 M | ||
|
Happiness Biotech Group Limited
HAPP
|
1.94 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
237 | $ 16.81 | -2.83 % | $ 786 M | ||
|
AgeX Therapeutics
AGE
|
186 | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
AstraZeneca PLC
AZN
|
206 | - | - | $ 96.9 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Arcturus Therapeutics Holdings
ARCT
|
21.2 | $ 7.58 | -3.19 % | $ 208 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
AbCellera Biologics
ABCL
|
173 | $ 4.08 | -7.39 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
129 | $ 1.61 | 1.26 % | $ 428 M | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 2.77 | -8.75 % | $ 259 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Coherus BioSciences
CHRS
|
656 | $ 1.6 | -2.15 % | $ 187 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
99.7 | $ 3.13 | 0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
189 | $ 30.12 | -1.94 % | $ 810 M | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
140 | $ 50.55 | -1.08 % | $ 13.7 B | ||
|
Arcutis Biotherapeutics
ARQT
|
291 | $ 21.54 | -0.16 % | $ 2.74 B | ||
|
Fortress Biotech
FBIO
|
325 | $ 2.39 | 3.91 % | $ 66.7 M | ||
|
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | ||
|
Fennec Pharmaceuticals
FENC
|
148 | $ 10.11 | 9.36 % | $ 289 M |